Genpime 250mg/31.25mg Injection
Marketer
Plus India
Salt Composition
Cefepime (250mg) + Tazobactum (31.25mg)
Overview Genpime 250mg/31.25mg Injection
The antibiotic combination injection, Genpime 250mg/31.25mg, combats bacterial infections by inhibiting microbial proliferation. Administered only by a healthcare provider, this medication requires adherence to the prescribed schedule; complete the full course regardless of symptom improvement. Commonly reported side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rashes), and localized injection site inflammation (redness, swelling, pain), typically resolving spontaneously. However, worsening side effects necessitate immediate medical attention. Seek emergency care for allergic reactions (skin rashes, itching, swelling, breathing difficulties). Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not affecting driving ability, refrain from driving if experiencing somnolence or dizziness.
Primary Ingredients of Genpime 250mg/31.25mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Genpime 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Genpime 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Genpime 250mg/31.25mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Genpime 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not advised.
How Genpime 250mg/31.25mg Injection works:
Genpime Injection, containing 250mg Cefepime and 31.25mg Tazobactum, utilizes a dual-action approach to combat bacterial infections. Cefepime, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial enzymes that would otherwise neutralize Cefepime. This synergistic combination broadens Cefepime's effectiveness by overcoming bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Genpime 250mg/31.25mg Injection concurrently with alcohol. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Genpime, 250mg/31.25mg, is typically deemed safe for use in pregnancy. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human clinical trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administering Genpime 250mg/31.25mg Injection while breastfeeding is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
Following administration of Genpime 250mg/31.25mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
For individuals with impaired kidney function, the administration of Genpime 250mg/31.25mg Injection requires careful monitoring. Dosage modification of Genpime 250mg/31.25mg Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Genpime 250mg/31.25mg Injection in patients with liver impairment appears to present a low risk. Existing evidence indicates dose modification might be unnecessary for this patient group. However, physician consultation is recommended.
What if you forget to take Genpime 250mg/31.25mg Injection :
Omit a Genpime 250mg/31.25mg Injection dose? Seek your physician's advice.
Facts to Know About Genpime 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobials |
3,018 People bought this recently